Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 901384107 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Glazer Capital, LLC
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Glazer Capital, LLC | 0% | ||
| Paul J. Glazer | 0% | ||
|
Beryl Capital Management LLC
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Beryl Capital Management LLC | 0% | ||
| Beryl Capital Management LP | 0% | ||
| Beryl Capital Partners II LP | 0% | ||
| David A. Witkin | 0% | ||
|
Goldman Sachs Group Inc
13G/A
Amendment 1
|
0% |
8/13/2025
Event 6/30/2025
|
|
| The Goldman Sachs Group, Inc. | 0% | ||
| Goldman Sachs & Co. LLC | 0% | ||
| Morgan Stanley 13G/A Amendment 2 | 0% |
6/6/2025
Event 5/30/2025
|
|
| Vanguard Group Inc 13G/A Amendment 3 | 5.4% |
4/30/2025
Event 3/31/2025
|
|
|
Glazer Capital, LLC
13G
|
5.3% |
4/15/2025
Event 4/8/2025
|
|
| Glazer Capital, LLC | 5.3% | ||
| Paul J. Glazer | 5.3% | ||
|
Beryl Capital Management LLC
13G
|
8.1% |
3/18/2025
Event 3/11/2025
|
|
| Beryl Capital Management LLC | 8.1% | ||
| Beryl Capital Management LP | 8.1% | ||
| Beryl Capital Partners II LP | 6.6% | ||
| David A. Witkin | 8.1% | ||
|
Kynam Capital Management, LP
13G/A
Amendment 1
|
0% |
3/17/2025
Event 3/11/2025
|
|
| Kynam Capital Management, LP | 0% | ||
| Kynam Capital Management GP, LLC | 0% | ||
| Yue Tang | 0% | ||
| Kynam Global Healthcare Master Fund, LP | 0% | ||
| Kynam Fund GP, LLC | 0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q2 | 3 | 96.0 k | $508 k |
| 2025 Q1 | 145 | 47.5 M | $235 M |
| 2024 Q4 | 121 | 46.0 M | $135 M |
| 2024 Q3 | 122 | 45.5 M | $215 M |
| 2024 Q2 | 123 | 51.4 M | $198 M |
| 2024 Q1 | 126 | 56.5 M | $303 M |
| 2023 Q4 | 128 | 58.6 M | $250 M |
| 2023 Q3 | 150 | 54.9 M | $215 M |
| 2023 Q2 | 156 | 49.9 M | $505 M |
| 2023 Q1 | 152 | 49.8 M | $508 M |
| 2022 Q4 | 148 | 35.9 M | $340 M |
| 2022 Q3 | 139 | 33.9 M | $494 M |
| 2022 Q2 | 137 | 34.6 M | $457 M |
| 2022 Q1 | 136 | 31.9 M | $544 M |
| 2021 Q4 | 134 | 18.8 M | $819 M |